IGM Biosciences Inc
(STU:1K0)
€
14.2
0.3 (2.16%)
Market Cap: 957.09 Mil
Enterprise Value: 756.44 Mil
PE Ratio: 0
PB Ratio: 7.59
GF Score: 33/100 IGM Biosciences Inc at Jefferies Healthcare Conference Transcript
Jun 08, 2023 / 05:30PM GMT
Release Date Price:
€10.2
(+4.08%)
Roger Song
Jefferies & Company, Inc. - Analyst
All right. Okay, everyone. Day two, 2023 Jefferies Healthcare Conference. My name is Roger Song, one of the senior analysts covering biotech semi-cap. Our next presenting company is IGM Biosciences. With me is CEO, Fred. Welcome.
Fred Schwarzer
IGM Biosciences, Inc. - President, CEO, & Director
Well, thanks very much. I'm going to impose a little bit on you and show a few slides that are just a little bit of a short recap of what we presented that at the time of ASCO last Friday night. And so, I thought maybe it would be worthwhile to just do a little bit of a quick overview.
Roger Song
Jefferies & Company, Inc. - Analyst
Excellent. Thank you.
Fred Schwarzer
IGM Biosciences, Inc. - President, CEO, & Director
I'll try to be quick. Okay. So I am going to make some forward-looking statements, and I'm afraid I have to refer you to our risk factors and all of our SEC filings.
So DR5 has been a target
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot